B. Moyer

发表

Cardiovascular alterations in Macaca monkeys exposed to stationary magnetic fields: experimental observations and theoretical analysis.

T F Budinger, T. Budinger, T. Tenforde, 1983, Bioelectromagnetics.

BIODISTRIBUTION AND AUTORADIOGRAPHIC LOCALIZATION OF I‐125-LABELED SYNTHETIC PEPTIDE IN AORTIC ATHEROSCLEROSIS IN CHOLESTEROL‐FED RABBITS

P. Lu, E. Herrold, J. Borer, 1996, American journal of therapeutics.

The Role of Pharmacokinetics and Allometrics in Imaging: Practical Issues and Considerations

B. Moyer, 2014 .

Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.

S. Vallabhajosula, B. Moyer, R. Dean, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.

W. Mcbride, D. Wilson, J. Taylor, 1996, Journal of medicinal chemistry.

Magnetic Resonance as a Tool for Pharmaco-Imaging

Simon-Peter Williams, T. Hu, B. Moyer, 2014 .

Regulatory Considerations Involved in Imaging

T. Hu, B. Moyer, N. Cheruvu, 2014 .

Small peptides radiolabeled with 99mTc.

B. Moyer, J. Lister‐James, T. Dean, 1996, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection.

S. Vallabhajosula, L. Bush, B. Moyer, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Labeled choline and phosphorylcholine: body distribution and brain autoradiography: concise communication.

C. Mathis, R. Friedland, T. Budinger, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Gallium-68 lipophilic complexes for labeling platelets.

C. Mathis, T. Budinger, Y. Yano, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Thyrotropin-releasing hormone labeled with 99mTc: a potential agent for neuroendocrinological studies.

B. Moyer, J. L. Pelletier, 1981, International journal of nuclear medicine and biology.

Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device.

W. Richenbacher, W. Cotts, S. Vance, 1998, ASAIO journal.

Quantitative Imaging Using Autoradiographic Techniques

B. Moyer, E. Solon, 2014 .

Chapter 6 Quantitative Imaging Using Autoradiographic Techniques

B. Moyer, E. Solon, 2013 .

CADMIUM LEVELS IN THE SHORELINE SEDIMENTS OF SAN FRANCISCO BAY

T. Budinger, B. Moyer, 1974 .

RAPID RADIATION DOSE ASSESSMENT FOR RADIOLOGICAL PUBLIC HEALTH EMERGENCIES: ROLES OF NIAID and BARDA

Brian R. Moyer, M. B. Grace, K. D. Cliffer, 2010, Health physics.

Pharmaco-Imaging in Drug and Biologics Development

T. Hu, B. Moyer, N. Cheruvu, 2014, AAPS Advances in the Pharmaceutical Sciences Series.

In vivo Leukocytes Labeling Using a Platelet Factor 4–Derived Heparin Binding Peptide Technetium Complex

B. Moyer, C. Nicodemus, J. Lister‐James, 1999, International Archives of Allergy and Immunology.

Imaging Platforms and Drug Development: An Introduction

Brian R. Moyer, B. Moyer, 2014 .

Biomarkers and imaging: physics and chemistry for noninvasive analyses.

J. Barrett, B. Moyer, 2009, Bioanalysis.

Localizing infection with a technetium-99m-labeled peptide: initial results

M. Tomas, C. Palestro, Y. Baran, 2001, Nuclear medicine communications.

From Molecular Science to the Treatment of Allergy

M. Manns, Jane Wilkinson, P. Hufnagl, 1999, International Archives of Allergy and Immunology.

Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development

Michael Fenech, C Norman Coleman, Brian R Moyer, 2014, Journal of radiological protection : official journal of the Society for Radiological Protection.

Refugee Medical Screening.

B. Moyer, K. Reese, 2020, Primary Care.

Preparedness for a ‘no-notice’ mass-casualty incident: a nuclear detonation scenario

K. D. Cliffer, J. Koerner, A. DiCarlo, 2021, International journal of radiation biology.

Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis.

R. Taillefer, J. Julian, Jeffrey S. Ginsberg, 2003, Archives of internal medicine.

Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.

J. Machac, S. Vallabhajosula, L. Bush, 1997, Journal of Nuclear Medicine.

Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.

L. Knight, A. Maurer, L. Bush, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS.

Chad M Hrdina, B. Maidment, C. Rios, 2016, Radiation protection dosimetry.

Positron emission tomography of the heart.

R. Huesman, S. Derenzo, T. Budinger, 1983, The Physiologist.

Pharmacokinetic considerations in the development of peptide-based imaging agents.

B. Moyer, R. Dean, J. Lister‐James, 1997, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

THE U.S. GOVERNMENT'S MEDICAL COUNTERMEASURE PORTFOLIO MANAGEMENT FOR NUCLEAR AND RADIOLOGICAL EMERGENCIES: SYNERGY FROM INTERAGENCY COOPERATION

Judith L Bader, Brian R Moyer, Richard Hatchett, 2011, Health physics.

Radionuclide and Nuclear Magnetic Resonance Methods of Evaluating Atherosclerosis

T. Budinger, M. Lipton, E. Ganz, 1983 .